Measurement based care is becoming behavioral health's real quality metric
Dr. Dereck Mush, MD, MBA
SonderMind
Connects people with licensed therapists and psychiatric care, with technology for measurement-based treatment.
What they do
SonderMind matches people with licensed therapists and psychiatric providers for in-person and virtual care, and builds tools that help clinicians track progress between sessions. The company was selected to participate in the FDA TEMPO pilot.
The record
- Vertical
- Mental & Behavioral Health
- Sub-segment
- Therapy access and measurement-based care
- Product type
- Platform software
- Stage
- Series C
- Headquarters
- Denver, United States
- Region
- North America
- Founded
- 2014
- Total funding
- $215M raised
Notable investors: General Catalyst, Kickstart Fund.
Also in Mental & Behavioral Health
Related on The Signal
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
Behavioral health benefits are consolidating around a few large distribution partnerships
Behavioral health benefits are consolidating around a few large distribution partnerships
Dr. Dereck Mush, MD, MBA
A CDMO partnership shows how gene therapy manufacturing is scaling for chronic disease
Dr. Dereck Mush, MD, MBA
Psychedelic assisted therapy is rebuilding on narrower, more rigorous trial designs
Dr. Dereck Mush, MD, MBA